Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
British Journal of Pharmacology|October 27, 2015
Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPARγ and 5-HT1A receptorsWilliam H Hind, Timothy J England, Saoirse E O'SullivanBritish Journal of Clinical Pharmacology|June 8, 2012
Is the cardiovascular system a therapeutic target for cannabidiol?Christopher P Stanley, William H Hind, Saoirse E O'SullivanCardiovascular Research|June 21, 2015
Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activationChristopher P Stanley, William H Hind, Cristina Tufarelli, et al.Pharmacological Research|September 17, 2016
The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteriesChristopher P Stanley, William H Hind, Christina Tufarelli, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 11, 2014
Cannabinoids in experimental stroke: a systematic review and meta-analysisTimothy J England, William H Hind, Nadiah A Rasid, et al.British Journal of Pharmacology|February 6, 2015
Endocannabinoids modulate human blood-brain barrier permeability in vitroWilliam H Hind, Cristina Tufarelli, Maria Neophytou, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 13, 2025
Treatment with a botanical mixture of cannabidiol:Δ9-tetrahydrocannabinol enhances microglial phagocytosis and shapes amyloid plaques in a mouse model of Alzheimer's diseaseSamuel Ruiz de Martín Esteban, M Teresa Grande, Ana M Martínez-Relimpio, et al.Pageof 1